Diagnosis and treatment of hepatocellular carcinoma.

@article{ElSerag2008DiagnosisAT,
  title={Diagnosis and treatment of hepatocellular carcinoma.},
  author={Hashem B. El-Serag and Jorge A. Marrero and L E Rudolph and K Rajender Reddy},
  journal={Gastroenterology},
  year={2008},
  volume={134 6},
  pages={
          1752-63
        }
}
  • Hashem B. El-Serag, Jorge A. Marrero, +1 author K Rajender Reddy
  • Published in Gastroenterology 2008
  • Medicine
  • The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy, typically diagnosed at an advanced stage in a symptomatic patient, and there were no known effective palliative or therapeutic options. However, the rising incidence of HCC in several regions around the world coupled with emerging evidence for efficacy of screening in high-risk patients, liver transplantation as a curative… CONTINUE READING

    Figures and Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 682 CITATIONS, ESTIMATED 52% COVERAGE

    Antiarrhythmic Agents and the Risk of Malignant Neoplasm of Liver and Intrahepatic Bile Ducts

    VIEW 12 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma

    VIEW 13 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.

    • Wei Guo, Yun-fan Sun, +20 authors Jia Fan
    • Biology, Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 2018
    VIEW 10 EXCERPTS
    CITES METHODS & BACKGROUND
    HIGHLY INFLUENCED

    Precision Molecular Pathology of Liver Cancer

    • Chen Liu
    • Medicine
    • Molecular Pathology Library
    • 2018
    VIEW 11 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    The long non-coding RNA AK023948 enhances tumor progression in hepatocellular carcinoma

    VIEW 7 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    FILTER CITATIONS BY YEAR

    2006
    2020

    CITATION STATISTICS

    • 43 Highly Influenced Citations

    • Averaged 61 Citations per year from 2017 through 2019

    • 27% Increase in citations per year in 2019 over 2018

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 105 REFERENCES

    Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

    Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebocontrolled trial (SHARP trial)

    • J. Llovet
    • J Clin Oncol 2007;25(18S [June
    • 2007

    Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a phase III randomized placebocontrolled trial (SHARP trial)

    • J. Llovet
    • J Clin Oncol 2007;25(18S [June
    • 2007